Allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia--recent progress

Research output: Contribution to journalArticle

Abstract

Allogeneic stem cell transplantation represents the most active form of anti-leukemic therapy in acute myeloid leukemia (AML). Advances in the transplant technology, availability of hematopoietic stem cells and supportive care not only have resulted in improved outcomes but also expanded the transplant options. However, post-transplant relapse and transplant-related mortality, especially those associated with allo-immune reaction after transplantation, remain as the leading causes of failure of this therapeutic approach. This review is going to focus on the recent progress to selectively enhance the anti-AML activity of conditioning and post-transplant allo-immune reaction.

Original languageEnglish
Pages (from-to)1944-1950
Number of pages7
JournalNippon rinsho. Japanese journal of clinical medicine
Volume67
Issue number10
Publication statusPublished - 2009 Oct

Fingerprint

Hematopoietic Stem Cell Transplantation
Acute Myeloid Leukemia
Transplants
Stem Cell Transplantation
Hematopoietic Stem Cells
Transplantation
Technology
Recurrence
Mortality
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

@article{2aa206a6a2b84a9aa5e91e036b722822,
title = "Allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia--recent progress",
abstract = "Allogeneic stem cell transplantation represents the most active form of anti-leukemic therapy in acute myeloid leukemia (AML). Advances in the transplant technology, availability of hematopoietic stem cells and supportive care not only have resulted in improved outcomes but also expanded the transplant options. However, post-transplant relapse and transplant-related mortality, especially those associated with allo-immune reaction after transplantation, remain as the leading causes of failure of this therapeutic approach. This review is going to focus on the recent progress to selectively enhance the anti-AML activity of conditioning and post-transplant allo-immune reaction.",
author = "Shinichiro Okamoto",
year = "2009",
month = "10",
language = "English",
volume = "67",
pages = "1944--1950",
journal = "Nihon rinsho. Japanese journal of clinical medicine",
issn = "0047-1852",
publisher = "Nipponrinsho Co., Inc.",
number = "10",

}

TY - JOUR

T1 - Allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia--recent progress

AU - Okamoto, Shinichiro

PY - 2009/10

Y1 - 2009/10

N2 - Allogeneic stem cell transplantation represents the most active form of anti-leukemic therapy in acute myeloid leukemia (AML). Advances in the transplant technology, availability of hematopoietic stem cells and supportive care not only have resulted in improved outcomes but also expanded the transplant options. However, post-transplant relapse and transplant-related mortality, especially those associated with allo-immune reaction after transplantation, remain as the leading causes of failure of this therapeutic approach. This review is going to focus on the recent progress to selectively enhance the anti-AML activity of conditioning and post-transplant allo-immune reaction.

AB - Allogeneic stem cell transplantation represents the most active form of anti-leukemic therapy in acute myeloid leukemia (AML). Advances in the transplant technology, availability of hematopoietic stem cells and supportive care not only have resulted in improved outcomes but also expanded the transplant options. However, post-transplant relapse and transplant-related mortality, especially those associated with allo-immune reaction after transplantation, remain as the leading causes of failure of this therapeutic approach. This review is going to focus on the recent progress to selectively enhance the anti-AML activity of conditioning and post-transplant allo-immune reaction.

UR - http://www.scopus.com/inward/record.url?scp=73449127287&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=73449127287&partnerID=8YFLogxK

M3 - Article

C2 - 19860195

AN - SCOPUS:73449127287

VL - 67

SP - 1944

EP - 1950

JO - Nihon rinsho. Japanese journal of clinical medicine

JF - Nihon rinsho. Japanese journal of clinical medicine

SN - 0047-1852

IS - 10

ER -